Skip to Main Content

CHAPTER SUMMARY FROM THE PHARMACOTHERAPY HANDBOOK

For the Chapter in the Schwinghammer, Handbook (not Wells Handbook anymore) please go to Chapter 18, Adrenal Gland Disorders.

KEY CONCEPTS

KEY CONCEPTS

  • imageGlucocorticoid secretion from the adrenal cortex is stimulated by adrenocorticotropic hormone (ACTH) or corticotropin that is released from the anterior pituitary in response to the hypothalamic-mediated release of corticotropin-releasing hormone (CRH).

  • imageTo ensure the proper treatment of Cushing syndrome, diagnostic procedures should (1) establish the presence of hypercortisolism and (2) discover the underlying etiology of the disease.

  • imageThe rationale for treating Cushing syndrome is to reduce the morbidity and mortality resulting from disorders such as diabetes mellitus, cardiovascular disease, and electrolyte abnormalities.

  • imageThe treatment of choice for both ACTH-dependent and ACTH-independent Cushing syndrome is surgery. Pharmacologic agents are reserved for adjunctive therapy, refractory cases, or inoperable disease.

  • imagePharmacologic agents that may be used to manage the patient with Cushing syndrome include steroidogenesis inhibitors, adrenolytic agents, neuromodulators of ACTH release, and glucocorticoid-receptor blocking agents.

  • imageSpironolactone, a competitive aldosterone-receptor antagonist, is the drug of choice in bilateral adrenal hyperplasia (BAH)–dependent hyperaldosteronism.

  • imageAddison’s disease (primary adrenal insufficiency) is a state of deficiency in cortisol, aldosterone, and various androgens due to the loss of function in all regions of the adrenal cortex.

  • imageSecondary adrenal insufficiency usually results from exogenous steroid use, leading to hypothalamic–pituitary–adrenal (HPA)–axis suppression followed by a decrease in ACTH release, and low levels of androgens and cortisol.

  • imageVirilism results from the excessive secretion of androgens from the adrenal gland and often manifests as hirsutism in females.

PATIENT CARE PROCESS

Patient Care Process for Cushing Syndrome

image

Collect

  • Patient characteristics (eg, age, sex, pregnant)

  • Patient medical history (personal and family)

  • Social history (eg, tobacco/ethanol use)

  • Iatrogenic causes of Cushing syndrome: current medications including corticosteroids (all routes, past and present), medroxyprogesterone acetate, megestrol acetate, gamma-hydroxybutyic acid, CYP3A4 inhibitors and inducers

  • Objective data

    • Blood pressure, heart rate, body mass index

    • Test for hypercortisolism: 24-hour UFC, midnight plasma cortisol, late-night salivary cortisol, or low-dose dexamethasone suppression test

    • Follow-up diagnostic tests to differentiate etiologies (see Fig. 93-4)

Assess

  • Presence of Cushing syndrome complications:

    • Metabolic: impaired glucose metabolism, dyslipidemia

    • Cardiovascular: hypertension, vascular damage, thrombosis, hypokalemia

    • Immunologic: bacterial, fungal, and viral infections; rebound autoimmunity Musculoskeletal: osteopenia/osteoporosis, myopathy

    • Neuropsychiatric: depression, anxiety, bipolar disorder

    • Reproductive: decreased libido, hypogonadism (men), menstrual irregularity (women)

    • Dermatologic: hirsutism, alopecia, hyperhidrosis

  • Physical exam: Peripheral obesity, fat accumulation (Buffalo Hump), rounded face (moon face), striae, ecchymosis, hyperpigmentation, acanthosis nigricans, acne, and thin skin

  • Current medications that may contribute to or worsen Cushing syndrome.

  • Results of follow-up diagnostic testing for etiology (see Fig. 93-4, and Tables 93-2 and 93-3)

  • Ability/willingness to pursue surgical/chemotherapeutic (if indicated) versus medical management

Plan*

  • Ensure proper administration of necessary corticosteroid therapy; discontinue unnecessary corticosteroid therapy, with taper if HPA axis integrity is suspect

  • Nondrug options for endogenous Cushing syndrome, depending on etiology: surgery, chemotherapy, irradiation, postoperative ...

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.